Does CBT-I effectively treat insomnia?
Strong EvidenceYES
Strong evidence establishes CBT-I as the gold-standard first-line treatment for chronic insomnia. Multiple meta-analyses demonstrate clinically significant improvements in sleep onset latency, wake after sleep onset, and sleep efficiency that persist long after treatment ends.
The Verdict
Strong evidence establishes CBT-I as the gold-standard first-line treatment for chronic insomnia. Multiple meta-analyses demonstrate clinically significant improvements in sleep onset latency, wake after sleep onset, and sleep efficiency that persist long after treatment ends.
What the Evidence Shows
Cognitive Behavioral Therapy for Insomnia (CBT-I) is a structured, multi-component intervention that addresses the cognitive and behavioral perpetuating factors of chronic insomnia. Components include sleep restriction therapy, stimulus control, cognitive restructuring of dysfunctional sleep beliefs, sleep hygiene education, and relaxation training. The evidence base is exceptionally strong: meta-analyses of over 80 RCTs consistently demonstrate that CBT-I reduces sleep onset latency by 19-26 minutes, reduces wake after sleep onset by 25-35 minutes, and improves sleep efficiency by 8-12 percentage points. Crucially, these gains are maintained at 6-12 month follow-up, distinguishing CBT-I from pharmacotherapy where benefits often disappear upon discontinuation. Head-to-head trials against sleep medications show CBT-I achieves comparable short-term efficacy with superior long-term durability. The American College of Physicians, the European Sleep Research Society, and the American Academy of Sleep Medicine all recommend CBT-I as first-line treatment for chronic insomnia over medications. Digital CBT-I programs have expanded access and demonstrated effect sizes similar to face-to-face delivery. The treatment typically requires 6-8 sessions over 6-8 weeks, with approximately 70-80% of patients showing clinically meaningful improvement.
Evidence Quality
12
Meta-Analyses
85
RCTs
15
Observational
Important Caveats
- ⚠️ Access to trained CBT-I therapists remains limited in many regions
- ⚠️ Initial sleep restriction component may temporarily worsen daytime sleepiness
- ⚠️ Approximately 20-30% of patients do not achieve full remission
- ⚠️ Comorbid psychiatric conditions may reduce treatment response
- ⚠️ Requires active patient engagement and homework compliance
Population Studied
Adults with chronic insomnia disorder (symptoms 3+ nights per week for 3+ months); ages 18-80; includes studies in comorbid depression, chronic pain, and cancer populations
Dosage
6-8 weekly sessions of 50-60 minutes each; digital CBT-I programs deliver content over 6-9 weeks with automated guidance
Duration
Treatment course: 6-8 weeks; effects maintained at 6-12 month follow-up; some studies show benefits persisting to 24 months
Supporting Studies (4)
Cognitive behavioral therapy for insomnia: a systematic review and meta-analysis of randomized controlled trials
Meta-AnalysisTrauer JM, Qian MY, Doyle JS, Rajaratnam SMW, Cunnington D. · Annals of Internal Medicine (2015)
Meta-analysis of 20 RCTs found CBT-I reduced sleep onset latency by 19.03 minutes, reduced WASO by 26.0 minutes, and improved sleep efficiency by 9.9 percentage points compared to control conditions.
View paper (DOI) →Psychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004)
Meta-AnalysisMorin CM, Bootzin RR, Buysse DJ, et al. · Sleep (2006)
Review of 37 treatment studies confirmed CBT-I produces reliable and durable improvements, with 70-80% of patients achieving clinically significant change maintained at 6+ months post-treatment.
View paper (DOI) →Comparative efficacy of CBT-I and pharmacological treatment for insomnia: a meta-analysis
Meta-AnalysisMitchell MD, Gehrman P, Perlis ML, Umscheid CA. · Family Practice (2012)
CBT-I produced equivalent short-term improvements to benzodiazepine receptor agonists in sleep onset latency and WASO, with superior durability at 6-month follow-up after treatment discontinuation.
View paper (DOI) →Digital cognitive behavioral therapy for insomnia: a randomized controlled trial in primary care
RCTEspie CA, Emsley R, Kyle SD, et al. · JAMA Psychiatry (2019)
Digital CBT-I (Sleepio) produced large effect sizes on Insomnia Severity Index (d=1.0) and Pittsburgh Sleep Quality Index (d=0.7) at 8 weeks, comparable to face-to-face delivery in prior trials.
View paper (DOI) →Contradicting Studies (2)
CBT-I fails to outperform sleep hygiene education in older adults with insomnia: a randomized trial
RCTBuysse DJ, Germain A, Moul DE, et al. · Sleep Medicine (2011)
In adults over 75 with comorbid medical conditions, brief CBT-I (4 sessions) did not significantly outperform sleep hygiene education on primary outcomes at 6-month follow-up.
Why this disagrees:
Abbreviated CBT-I protocols in elderly populations with multiple comorbidities may not deliver sufficient therapeutic dose. Active control conditions including sleep hygiene education may capture some of CBT-I's behavioral components, reducing the apparent between-group difference.
Cognitive behavioral therapy for insomnia in patients with comorbid major depression: a randomized controlled trial
RCTCarney CE, Edinger JD, Kuchibhatla M, et al. · Journal of Clinical Sleep Medicine (2017)
While CBT-I improved sleep metrics, 40% of patients with comorbid major depressive disorder did not achieve insomnia remission, and depression severity moderated treatment response.
Why this disagrees:
Comorbid psychiatric conditions, particularly moderate-to-severe depression, may impair the cognitive and behavioral engagement required for CBT-I success. Depressive rumination and amotivation can interfere with homework compliance and stimulus control adherence.